Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Ternium, Lowers Price Target to $39

Morgan Stanley Maintains Equal-Weight on Ternium, Lowers Price Target to $39

Morgan Stanley analyst Carlos De Alba maintains Ternium (NYSE:TX) with a Equal-Weight and lowers the price target from $48 to $39.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Morgan Stanley analyst Carlos De Alba maintains Ternium (NYSE:TX) with a Equal-Weight and lowers the price target from $48 to $39.

HYTN Awarded Medical Cannabis Sales Licence By Health Canada

By Vuk Zdinjak

August 23, 9:49 AM

HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes.

CSE:EMH

News
Tech

Steal Deal: Apple’s 13-inch M2 MacBook Air Is Down To Its All-Time Low Price

By Rounak Jain

July 5, 9:52 AM

Apple's 13-inch M2 MacBook Air is available at an all-time low price of $979 on B&H Photo, after a discount of $120.

AAPL

Analyst Ratings

Analyst Expectations for Ovintiv’s Future

By Benzinga Insights

June 12, 3:02 PM

Within the last quarter, Ovintiv (NYSE:OVV) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

OVV

Cowen & Co. Maintains Outperform on Core Scientific, Lowers Price Target to $3.75

By Benzinga Newsdesk

September 16, 9:15 AM

Cowen & Co. analyst Stephen Glagola maintains Core Scientific (NASDAQ:CORZ) with a Outperform and lowers the price target from $4 to $3.75.

CORZ

Morgan Stanley Maintains Equal-Weight on Ternium, Lowers Price Target to $39

Related Posts

HYTN Awarded Medical Cannabis Sales Licence By Health Canada

Steal Deal: Apple’s 13-inch M2 MacBook Air Is Down To Its All-Time Low Price

Analyst Expectations for Ovintiv’s Future

Cowen & Co. Maintains Outperform on Core Scientific, Lowers Price Target to $3.75